• Maze Therapeutics (NASDAQ:MAZE) Earns Buy Rating from Analysts at Guggenheim

    Source: Buzz FX / 25 Feb 2025 09:50:20   America/Chicago


    Maze Therapeutics (NASDAQ:MAZE) Earns Buy Rating from Analysts at Guggenheim Written by MarketBeat February 25, 2025 Share Link copied to clipboard. Stock analysts at Guggenheim assumed coverage on shares of Maze Therapeutics ( NASDAQ:MAZE
    Read more...
Share on,